These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 35189334)

  • 21. Evaluation of data completeness in the electronic health record for the purpose of patient recruitment into clinical trials: a retrospective analysis of element presence.
    Köpcke F; Trinczek B; Majeed RW; Schreiweis B; Wenk J; Leusch T; Ganslandt T; Ohmann C; Bergh B; Röhrig R; Dugas M; Prokosch HU
    BMC Med Inform Decis Mak; 2013 Mar; 13():37. PubMed ID: 23514203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials.
    Ateya MB; Delaney BC; Speedie SM
    BMC Med Inform Decis Mak; 2016 Jan; 16():1. PubMed ID: 26754574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical records-based chronic kidney disease phenotype for clinical care and "big data" observational and genetic studies.
    Shang N; Khan A; Polubriaginof F; Zanoni F; Mehl K; Fasel D; Drawz PE; Carrol RJ; Denny JC; Hathcock MA; Arruda-Olson AM; Peissig PL; Dart RA; Brilliant MH; Larson EB; Carrell DS; Pendergrass S; Verma SS; Ritchie MD; Benoit B; Gainer VS; Karlson EW; Gordon AS; Jarvik GP; Stanaway IB; Crosslin DR; Mohan S; Ionita-Laza I; Tatonetti NP; Gharavi AG; Hripcsak G; Weng C; Kiryluk K
    NPJ Digit Med; 2021 Apr; 4(1):70. PubMed ID: 33850243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating eligibility criteria of oncology trials using real-world data and AI.
    Liu R; Rizzo S; Whipple S; Pal N; Pineda AL; Lu M; Arnieri B; Lu Y; Capra W; Copping R; Zou J
    Nature; 2021 Apr; 592(7855):629-633. PubMed ID: 33828294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A knowledge base of clinical trial eligibility criteria.
    Liu H; Chi Y; Butler A; Sun Y; Weng C
    J Biomed Inform; 2021 May; 117():103771. PubMed ID: 33813032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leveraging Real-World Data for the Selection of Relevant Eligibility Criteria for the Implementation of Electronic Recruitment Support in Clinical Trials.
    Melzer G; Maiwald T; Prokosch HU; Ganslandt T
    Appl Clin Inform; 2021 Jan; 12(1):17-26. PubMed ID: 33440429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-World Data for Planning Eligibility Criteria and Enhancing Recruitment: Recommendations from the Clinical Trials Transformation Initiative.
    Evans SR; Paraoan D; Perlmutter J; Raman SR; Sheehan JJ; Hallinan ZP
    Ther Innov Regul Sci; 2021 May; 55(3):545-552. PubMed ID: 33393014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards clinical data-driven eligibility criteria optimization for interventional COVID-19 clinical trials.
    Kim JH; Ta CN; Liu C; Sung C; Butler AM; Stewart LA; Ena L; Rogers JR; Lee J; Ostropolets A; Ryan PB; Liu H; Lee SM; Elkind MSV; Weng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):14-22. PubMed ID: 33260201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.
    Rogers JR; Lee J; Zhou Z; Cheung YK; Hripcsak G; Weng C
    J Am Med Inform Assoc; 2021 Jan; 28(1):144-154. PubMed ID: 33164065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Phenotyping Algorithms for the Identification of Organ Transplant Recipients: Cohort Study.
    Wheless L; Baker L; Edwards L; Anand N; Birdwell K; Hanlon A; Chren MM
    JMIR Med Inform; 2020 Dec; 8(12):e18001. PubMed ID: 33156808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium.
    Solà E; Pose E; Campion D; Piano S; Roux O; Simon-Talero M; Uschner F; de Wit K; Zaccherini G; Alessandria C; Beuers U; Caraceni P; Francoz C; Mookerjee RP; Trebicka J; Vargas V; Serra M; Torres F; Montagnese S; Krag A; Hernaez R; Korenjak M; Watson H; Abraldes JG; Kamath PS; Ginès P;
    J Hepatol; 2021 Jan; 74(1):200-219. PubMed ID: 32896580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The link between kidney disease and cancer: complications and treatment.
    Malyszko J; Tesarova P; Capasso G; Capasso A
    Lancet; 2020 Jul; 396(10246):277-287. PubMed ID: 32711803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Site engagement for multi-site clinical trials.
    Goodlett D; Hung A; Feriozzi A; Lu H; Bekelman JE; Mullins CD
    Contemp Clin Trials Commun; 2020 Sep; 19():100608. PubMed ID: 32685765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broadening Eligibility Criteria for Oncology Clinical Trials: Current Advances and Future Directions.
    Rahman NA; Ison G; Beaver JA
    Clin Pharmacol Ther; 2020 Sep; 108(3):419-421. PubMed ID: 32640034
    [No Abstract]   [Full Text] [Related]  

  • 35. A Framework for Advancing Precision Medicine in Clinical Trials for Mental Disorders.
    Lenze EJ; Rodebaugh TL; Nicol GE
    JAMA Psychiatry; 2020 Jul; 77(7):663-664. PubMed ID: 32211837
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network.
    Chen R; Ryan P; Natarajan K; Falconer T; Crew KD; Reich CG; Vashisht R; Randhawa G; Shah NH; Hripcsak G
    JCO Clin Cancer Inform; 2020 Mar; 4():171-183. PubMed ID: 32134687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6. Glycemic Targets:
    American Diabetes Association
    Diabetes Care; 2020 Jan; 43(Suppl 1):S66-S76. PubMed ID: 31862749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data.
    Phillips CA; Razzaghi H; Aglio T; McNeil MJ; Salvesen-Quinn M; Sopfe J; Wilkes JJ; Forrest CB; Bailey LC
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27876. PubMed ID: 31207054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World.
    Karim S; Xu Y; Kong S; Abdel-Rahman O; Quan ML; Cheung WY
    Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e160-e166. PubMed ID: 31133363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving pragmatic clinical trial design using real-world data.
    Shortreed SM; Rutter CM; Cook AJ; Simon GE
    Clin Trials; 2019 Jun; 16(3):273-282. PubMed ID: 30866672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.